-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, H3FIIJDTCr1EnOzg55G0iigappf1wVPm/oC0c3/cl0UKZJO/Ge60b2/cdmtQSNGj SCjfOAt7OK1VXCbHGX1Niw== 0001013594-10-000769.txt : 20101227 0001013594-10-000769.hdr.sgml : 20101224 20101227113758 ACCESSION NUMBER: 0001013594-10-000769 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20101227 DATE AS OF CHANGE: 20101227 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: VENTRUS BIOSCIENCES INC CENTRAL INDEX KEY: 0001426800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-85836 FILM NUMBER: 101273730 BUSINESS ADDRESS: STREET 1: 787 7TH AVENUE STREET 2: 48TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: (212) 554-4388 MAIL ADDRESS: STREET 1: 787 7TH AVENUE STREET 2: 48TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ELLIOTT ASSOCIATES, L.P. CENTRAL INDEX KEY: 0000904495 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] IRS NUMBER: 222140975 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 712 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2125062999 MAIL ADDRESS: STREET 1: 712 FIFTH AVE CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: ELLIOTT ASSOCIATES LP DATE OF NAME CHANGE: 19930513 SC 13G 1 ventrus13g-122710.htm DECEMBER 27, 2010 ventrus13g-122710.htm
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549

SCHEDULE 13G
(RULE 13d - 102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b)

(Amendment No. )*

Ventrus Biosciences, Inc.
(Name of Issuer)

Common Stock
(Title of Class of Securities)

922822101
(CUSIP Number)

December 15, 2010
(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[ ]Rule 13d-1(b)
[x]Rule 13d-1(c)
[ ]Rule 13d-1(d)


*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).



 
 

 

1.NAMES OF REPORTING PERSONS
 
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Elliott Associates, L.P.

2.CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)[ ]
(b)[ ]

3.SEC USE ONLY

4.CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

5.SOLE VOTING POWER

622,158

6.SHARED VOTING POWER

0

7.SOLE DISPOSITIVE POWER

622,158

8.SHARED DISPOSITIVE POWER

0

9.AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

622,158

10.CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
          EXCLUDES CERTAIN SHARES*[ ]

11.PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

9.2%

12.TYPE OF REPORTING PERSON*

PN

*SEE INSTRUCTIONS BEFORE FILLING OUT!

 
 

 
ITEM 1(a).   Name of Issuer:

Ventrus Biosciences, Inc. (“Issuer”)

Item 1(b).    Address of Issuer's Principal Executive Offices:

787 Seventh Avenue, 48th Floor
New York, New York 10019

Item 2(a).    Name of Persons Filing:

The name of the persons filing this statement on Schedule 13G are: Elliott Associates, L.P. and its wholly-owned subsidiaries (collectively, "Elliott Associates").  Paul E. Singer ("Singer"), Elliott Capital Advisors, L.P., a Delaware limited partnership ("Capital Advisors"), which is controlled by Singer, and Elliott Special GP, LLC, a Delaware limited liability company (“Special GP”), which is controlled by Singer, are the general partners of Elliott Associates.

Item 2(b).
Address of Principal Business Office or, if None, Residence:

The business address of Elliott Associates, Capital Advisors, Singer and Special GP is 712 Fifth Avenue, 36th Floor, New York, New York 10019.

Item 2(c).    Citizenship:

Each of Elliott Associates and Capital Advisors is a limited partnership formed under the laws of the State of Delaware.

Special GP is a limited liability company formed under the laws of the State of Delaware.

Singer is a U.S. citizen.

Item 2(d).   Title of Class of Securities:

Common Stock, par value $.001 per share (“Common Stock”).

Item 2(e).   CUSIP Number:

922822101

Item 3.        If This Statement is Filed Pursuant to Rule 13d 1(b),
                    or 13d-2(b) or (c), Check Whether the Person Filing
                    is a:
 
(a)[ ]Broker or dealer registered under Section 15 of the Exchange Act.
 
(b)[ ]Bank as defined in Section 3(a)(6) of the Exchange Act.
 
(c)[ ]Insurance company defined in Section 3(a)(19) of the Exchange Act.
 
 
 

 
(d)[ ]Investment company registered under Section 8 of the Investment Company Act.
 
(e)[ ]An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).
 
(f) [ ]An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).
 
(g)[ ]A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).
 
(h)[ ]A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.
 
(i) [ ]A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
 
(j) [ ]Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
 
 
If this statement is filed pursuant to Rule 13d-1(c), check this box [x]

Item 4.              Ownership.

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

(a)Amount beneficially owned:

 
Elliott Associates beneficially owns 622,158 shares of Common Stock.  Elliott Associates owns its 622,158 shares of Common Stock through Manchester Securities Corp., a New York corporation and a wholly-owned subsidiary of Elliott Associates.

(b)Percent of class:

 
Elliott Associates’ ownership of 622,158 shares of Common Stock constitutes 9.2% of all of the outstanding shares of Common Stock.

(c)Number of shares as to which such person has:

 
(i)      Sole power to vote or to direct the vote

 
Elliott Associates has sole power to vote or direct the vote of 622,158 shares of Common Stock.

 
(ii)     Shared power to vote or to direct the vote

 
Not applicable.

 
(iii)   Sole power to dispose or to direct the disposition of

 
Elliott Associates has sole power to dispose or direct the disposition of 622,158 shares of Common Stock.


 
 

 

(iv)    Shared power to dispose or to direct the disposition of

 
Not applicable.
 
 
Item 5.        Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following [  ].

Item 6.        Ownership of More than Five Percent on Behalf of Another Person.

 
Not applicable.

Item 7.        Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

Elliott Associates holds its 622,158 shares of Common Stock through Manchester Securities Corp., a New York corporation that is a wholly-owned subsidiary of Elliott Associates.  

Item 8.        Identification and Classification of Members of the Group.

Not applicable.

Item 9.        Notice of Dissolution of Group.

 
Not applicable.

Item 10.     Certification.

By signing below the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 
 

 

SIGNATURES

After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct.

Dated: December 27, 2010

ELLIOTT ASSOCIATES, L.P.
By: Elliott Capital Advisors, L.P., as General Partner
By: Braxton Associates, Inc., as General Partner


By:  /s/ Elliot Greenberg
                            Elliot Greenberg
                            Vice President


-----END PRIVACY-ENHANCED MESSAGE-----